Biotechnology
Healthcare
Investing News
Life Style
Market News
Medical Use
Pharmaceutical
Products
The Market Buzz
Your Environment
FDA Cites Drawbacks at Emergent BioSolutions Vaccine Plant
On Wednesday, The Food and Drug Administration revealed that Emergent BioSolutions (NYSE: EBS) Baltimore plant, which manufactured Johnson and Johnson Covid-19 vaccines, was unsanitary and unsuitable to produce the...